These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 25677585
1. Laparoscopic Splenectomy as Quaternary Cytoreduction for Isolated Parenchymal Splenic Recurrence of Epitelial Tubo-Ovarian Cancer: Report of a Case and Literature Review. Sorbi F, Prosperi P, Villanucci A, Berti V, Sisti G, Fambrini M. Gynecol Obstet Invest; 2015; 80(4):265-71. PubMed ID: 25677585 [Abstract] [Full Text] [Related]
3. Laparoscopic Splenectomy for Secondary Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique. Gallotta V, Nero C, Lodoli C, Chiantera V, Pacelli F, Fagotti A, Costantini B, Scambia G. J Minim Invasive Gynecol; 2016; 23(3):425-8. PubMed ID: 26776676 [Abstract] [Full Text] [Related]
4. Splenectomy as Part of Cytoreductive Surgery in Recurrent Epithelial Ovarian Cancer. Bacalbasa N, Balescu I, Dima S, Brasoveanu V, Popescu I. Anticancer Res; 2015 Sep; 35(9):5097-101. PubMed ID: 26254413 [Abstract] [Full Text] [Related]
7. Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer. Xiang L, Tu Y, He T, Shen X, Li Z, Wu X, Yang H. J Gynecol Oncol; 2016 Nov; 27(6):e62. PubMed ID: 27550408 [Abstract] [Full Text] [Related]
13. The impact of ultra-radical surgery in the management of patients with stage IIIC and IV epithelial ovarian, fallopian tube, and peritoneal cancer. Turnbull HL, Akrivos N, Wemyss-Holden S, Maiya B, Duncan TJ, Nieto JJ, Burbos N. Arch Gynecol Obstet; 2017 Mar; 295(3):681-687. PubMed ID: 27995370 [Abstract] [Full Text] [Related]
16. Splenectomy for solitary splenic metastasis of ovarian cancer. Koh YS, Kim JC, Cho CK. BMC Cancer; 2004 Dec 22; 4():96. PubMed ID: 15615591 [Abstract] [Full Text] [Related]
17. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience. Bacalbasa N, Balescu I, Dima S, Brasoveanu V, Popescu I. Anticancer Res; 2015 Oct 22; 35(10):5649-54. PubMed ID: 26408738 [Abstract] [Full Text] [Related]
18. [Splenectomy in epithelial ovarian cancer: analysis of 32 cases]. Zheng AW, Zheng F, Chen YQ, Zhu HN, Qian JH. Zhonghua Fu Chan Ke Za Zhi; 2008 Mar 22; 43(3):197-200. PubMed ID: 18788569 [Abstract] [Full Text] [Related]
19. Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer. Tanner EJ, Long KC, Feffer JB, Leitao MM, Abu-Rustum NR, Barakat RR, Chi DS, Gardner GJ. Gynecol Oncol; 2013 Jan 22; 128(1):28-33. PubMed ID: 23017819 [Abstract] [Full Text] [Related]
20. Laparoscopic splenectomy both for primary cytoreductive surgery for advanced ovarian cancer and for secondary surgery for isolated spleen recurrence: feasibility and technique. Macciò A, Sanna E, Lavra F, Chiappe G, Petrillo M, Madeddu C. BMC Surg; 2021 Oct 28; 21(1):380. PubMed ID: 34711237 [Abstract] [Full Text] [Related] Page: [Next] [New Search]